Ra Capital Management as of Sept. 30, 2017
Portfolio Holdings for Ra Capital Management
Ra Capital Management holds 27 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ascendis Pharma A S (ASND) | 18.3 | $202M | 5.6M | 36.25 | |
| Wave Life Sciences (WVE) | 13.9 | $154M | 7.1M | 21.75 | |
| Avexis | 10.8 | $120M | 1.2M | 96.73 | |
| Biohaven Pharmaceutical Holding | 6.7 | $75M | 2.0M | 37.38 | |
| Achillion Pharmaceuticals | 5.5 | $61M | 14M | 4.49 | |
| Ignyta | 4.6 | $51M | 4.1M | 12.35 | |
| G1 Therapeutics (GTHX) | 4.5 | $50M | 2.7M | 18.55 | |
| Kala Pharmaceuticals | 4.4 | $48M | 2.1M | 22.84 | |
| Myovant Sciences | 4.0 | $44M | 2.8M | 15.47 | |
| AVEO Pharmaceuticals | 3.7 | $41M | 11M | 3.65 | |
| BioCryst Pharmaceuticals (BCRX) | 3.3 | $37M | 7.0M | 5.24 | |
| Zogenix | 3.1 | $35M | 992k | 35.05 | |
| Insmed (INSM) | 2.0 | $23M | 723k | 31.21 | |
| Kadmon Hldgs | 2.0 | $22M | 6.7M | 3.35 | |
| Acorda Therapeutics | 1.9 | $21M | 900k | 23.65 | |
| Immunomedics | 1.9 | $21M | 1.5M | 13.98 | |
| Ra Pharmaceuticals | 1.8 | $20M | 1.4M | 14.60 | |
| Sangamo Biosciences (SGMO) | 1.7 | $19M | 1.3M | 15.00 | |
| Dicerna Pharmaceuticals | 1.3 | $14M | 2.4M | 5.75 | |
| Aquinox Pharmaceuticals | 0.9 | $10M | 711k | 14.19 | |
| Clementia | 0.9 | $9.9M | 585k | 16.89 | |
| Tg Therapeutics (TGTX) | 0.8 | $8.3M | 700k | 11.85 | |
| Krystal Biotech (KRYS) | 0.6 | $7.0M | 700k | 9.97 | |
| Vanda Pharmaceuticals (VNDA) | 0.4 | $4.4M | 244k | 17.90 | |
| Kalvista Pharmaceuticals (KALV) | 0.4 | $4.4M | 591k | 7.36 | |
| Chiasma | 0.3 | $3.6M | 1.4M | 2.55 | |
| Proteon Therapeutics | 0.2 | $2.7M | 1.3M | 2.00 |
